Search

Author/Creator Jones, Rhys D.O.

1. A pharmacokinetic–pharmacodynamic model for the MET tyrosine kinase inhibitor, savolitinib, to explore target inhibition requirements for anti‐tumour activity. (7th December 2020)

Authors:
Jones, Rhys D.O.; Grondine, Mike; Borodovsky, Alexandra; San Martin, Maryann; DuPont, Michelle; D'Cruz, Celina; Schuller, Alwin; Henry, Ryan; Barry, Evan; Castriotta, Lillian; Anjum, Rana; Petersson, Klas; Sahota, Tarjinder; Ahmed, Ghada F.
Journal:
British journal of pharmacology
Issue:
Volume 178:Number 3(2021)
Page Start:
600
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades. (June 2020)

Authors:
Davies, Michael; Jones, Rhys D.O.; Grime, Ken; Jansson-Löfmark, Rasmus; Fretland, Adrian J.; Winiwarter, Susanne; Morgan, Paul; McGinnity, Dermot F.
Journal:
Trends in pharmacological sciences
Issue:
Volume 41:Number 6(2020)
Page Start:
390
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗